National Association of Testing Authorities, Australia
Scope of Accreditation
SA Pathology
Site
Royal Adelaide Hospital
Accreditation No.
2348
Site No.
24039
Date of Accreditation
07 Sep 2017
Contact
Mr Jason Graefling P: +61 (08) 82223137
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Anatomical Pathology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
15 May 2023
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Other body fluids; Sputum; Urine; Washings or brushings from other sites | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of nipple discharge or smears from squamous mucosal sites for the detection of cancerous or precancerous changes | Anus smears; Lip smears; Mouth smears; Nipple discharge; Nose smears; Skin smears | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsyFNA Attendance, Screening and Reporting only | Fine needle aspirates (FNA) | Cytological examination; Review and reporting of fine needle aspiration samples |
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin-fixed tissue; Fresh tissue | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
| Anatomical pathology - Tissue pathology - Gene probes using paraffin fluorescence in situ hybridisation (FISH) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
| Anatomical pathology - Tissue pathology - Gene probes using paraffin in situ hybridisation techniques (chromogenic/silver) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue | Intra-operative consultation and examination of biopsy material |
| Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigation | Formalin-fixed paraffin-embedded (FFPE) tissues; Fresh tissue | Detection of antigenic targets - Various |
| Anatomical pathology - Tissue pathology - Immunohistochemical investigation | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
| Anatomical pathology - Tissue pathology - Mortuary facilities | Body; Body parts | Assessment - Level 3 mortuary |
Cellular Therapies Laboratory
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
15 May 2023
| Service | Product | Determinant |
|---|---|---|
| Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cellsProduct received from Central Adelaide Local Health Network (17274 18964), Women's and Children's Health Network (19268 21912) and Southern Adelaide Local Health Network (21054 25324) | Bone marrow; Haemopoietic progenitor cells | Processing; Storage (includes freezing/thawing) |
| Haemopoietic progenitor cells | Enumeration of CD34+ cells |
Core Laboratory – Biochemistry
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
15 May 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Plasma; Serum | Ethanol; Paracetamol (acetaminophen) |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Plasma; Serum | Cyclosporin; Digoxin; Tacrolimus |
| Carbamazepine; Gentamicin (cidomycin, septopal, genticyn, garamycin); Lithium; Phenobarbitone; Phenytoin (dilantin); Salicylate; Theophylline; Tobramycin; Valproate (valproic acid, epilim); Vancomycin | ||
| Chemical pathology - Detection and/or quantitation of tumour markers | Plasma; Serum | α-Fetoprotein (AFP) |
| Prostate specific antigen (PSA); Prostate specific antigen (PSA) - Free | ||
| Thyroglobulin | ||
| CA125 antigen (CA125); CA15-3 antigen (CA15-3); CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA) | ||
| Plasma; Serum; Urine | β2-Microglobulin (B2M) | |
| Pleural fluid | CA125 antigen (CA125); CA15-3 antigen (CA15-3); CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA); Human chorionic gonadotropin (hCG); Thyroglobulin | |
| Serum | Neuron specific enolase (NSE) | |
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma; Serum | Anti-Mullerian hormone (AMH); Cortisol; Dehydroepiandrosterone sulfate (DHEAS); Follicle stimulating hormone (FSH); Insulin; Luteinising hormone (LH); Macroprolactin; Oestradiol; Parathyroid hormone (PTH); Progesterone; Prolactin |
| Adrenocorticotropic hormone (ACTH); Parathyroid hormone (PTH); Sex hormone binding globulin (SHBG); Testosterone | ||
| Plasma; Serum; Urine | C-peptide | |
| Saliva | Cortisol | |
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Chemical pathology - Further investigation of cardiac function | Plasma; Serum | N-Terminal-pro b-type natriuretic peptide (NT-proBNP); Troponin |
| Creatine kinase MB (CKMB); N-Terminal-pro b-type natriuretic peptide (NT-proBNP); Troponin | ||
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Plasma; Serum | HDL - Quantitation |
| Chemical pathology - Further investigation of renal and/or hepatic function | Plasma; Serum | Caeruloplasmin; Haptoglobins; α1-Antitrypsin |
| Chemical pathology - Haem related pigments and precursors (excluding porphyria) | Cerebrospinal fluid (CSF) | Xanthochromia |
| Plasma; Serum | Myoglobin | |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Ascitic fluid; Cerebrospinal fluid (CSF); Dialysates; Drainage fluid; Peritoneal fluid; Pleural fluid; Vitreous humor | Albumin; Alkaline phosphatase; Amylase; Aspartate transaminase; Bicarbonate; Bilirubin - Total; Calcium - Total; Chloride; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; HDL - Quantitation; Lactate; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea; γ-Glutamyltransferase |
| Cerebrospinal fluid (CSF) | Glucose; Lactate; Protein - Total | |
| Plasma; Serum | Alanine aminotransferase; Albumin; Alkaline phosphatase; Ammonia; Amylase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Conjugated; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Chloride; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; Lactate; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea; γ-Glutamyltransferase | |
| Plasma; Serum; Urine | Osmolality | |
| Urine | Albumin; Calcium - Total; Chloride; Creatinine; Magnesium; Microalbumin; Phosphate; Potassium; Protein - Total; Sodium; Urate; Urea | |
| Chemical pathology - Investigation for folate deficiency | Plasma; Serum | Folate; Red blood cell folate |
| Chemical pathology - Investigation of maternal markers to detect foetal abnormality | Plasma; Serum | Free β-human chorionic gonadotropin (free β-hCG); Pregnancy associated plasma protein A (PAPP-A) |
| Chemical pathology - Iron studies | Plasma; Serum | Ferritin; Iron; Transferrin |
| Chemical pathology - Markers of bone metabolism | Plasma; Serum | c-Telopeptide (CTx) |
| Procollagen type 1 N-terminal propeptide (P1NP) | ||
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Haemoglobin (Hb); Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
| Chemical pathology - Quantitation of precursor and intermediary metabolites | Cerebrospinal fluid (CSF); Vitreous humor | β-Hydroxybutyrate |
| Plasma; Serum | β-Hydroxybutyrate | |
| Homocysteine | ||
| Chemical pathology - Quantitation of vitamins | Plasma; Serum | Cobalamin (vitamin B12); Holotranscobalamin (active vitamin B12) |
| Chemical pathology - Tests for thyroid function | Plasma; Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
| Haematology - Assessment of haemolysis or metabolic enzymes (red cell enzyme assays) | Blood | Glucose-6-phosphate dehydrogenase (G6PD) |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Plasma; Serum | Anti-thyroglobulin antibodies (Tg) |
| Anti-thyroid peroxidase antibodies (TPO) | ||
| Rheumatoid factor | ||
| Serum | Anti-cyclic citrullinated peptide antibodies (CCP); Anti-thyrotropin receptor antibodies (TSHR) | |
| Immunopathology - Quantitation of complement proteins | Plasma; Serum | Complement components C3 and C4 |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Plasma; Serum | Total immunoglobulin A; Total immunoglobulin G; Total immunoglobulin M |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Plasma; Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Plasma; Serum | Human T-lymphotropic virus type I/II (HTLV-I/II) |
| Cytomegalovirus antibody (anti-CMV) IgG; Cytomegalovirus antibody (anti-CMV) IgM; Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis A virus antibody (anti-HAV) - Total; Hepatitis B virus core antibody (anti-HBc) - IgM; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis B virus surface antigen (HBs Ag) neutralisation; Hepatitis C virus antibody (anti-HCV) - IgG; Herpes simplex virus type 2 antibody (anti-HSV2) - IgG; Herpes simplex type 1 antibody (anti-HSV1) - IgG; Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Human immunodeficiency virus type 1/2 (HIV-1/2) antigen; Rubella IgG antibody; Rubella IgM antibody; Syphilis Treponema pallidum antibody; Toxoplasma gondii IgG antibody; Toxoplasma gondii IgM antibody | ||
| Serum | Helicobacter pylori IgG antibody |
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
15 May 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Plasma; Serum | Lipoprotein a |
Core Laboratory – Haematology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
15 May 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material; Histological examination |
| Haematology - Examination of blood films by special staining | Blood | Iron |
| Malaria | ||
| Haematology - Full blood examination | Blood | Morphology |
| Differential number; Morphology | ||
| Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Red blood cell distribution width (RDW); Red blood cell index or indices; Reticulocyte haemoglobin equivalent (Ret-He); Reticulocytes | ||
| Morphology | ||
| Fluids | Differential number; Erythrocyte count (red blood cell count, RBCC); Leucocyte count (white blood cell count, WBCC) | |
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | Activated partial thromboplastin time (APTT); D-dimer; Fibrinogen; International normalised ratio (INR) |
| Blood; Plasma | Anti-Xa - Apixaban; Anti-Xa - Fondaparinux; Anti-Xa activity - Clexane - Low molecular weight heparin; Anti-Xa activity - Unfractionated heparin; Danaparoid sodium | |
| Haematology - Investigation of haemoglobinopathy (excluding thalassemia) | Blood | Haemoglobin fraction (S, C, D, E) - Quantitation; Other abnormal haemoglobins |
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Blood | Malaria |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Blood | Infectious mononucleosis |
Covid Clinic
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
15 May 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Blood | Anion gap; Calcium - Ionised; Chloride; Creatinine; Glucose; Potassium; Sodium; Total carbon dioxide (TCO2); Urea |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
| Haematology - Full blood examination | Blood | Haematocrit (packed cell volume, PCV); Haemoglobin (Hb) |
Emergency Department
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
15 May 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb) |
Haemostasis Laboratory
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
15 May 2023
| Service | Product | Determinant |
|---|---|---|
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | Platelet function (PFA) |
| Blood; Plasma | Factor XIII | |
| Kaolin clotting time | ||
| ADAMTS-13 activity | ||
| Lupus anticoagulant | ||
| Von Willebrand factor (vWF) activity - Ristocetin co-factor assay | ||
| Anti-Xa - Dabigatran; Anti-thrombin III; Circulating coagulation factor inhibitors; Collagen binding activity; Factor II; Factor IX; Factor V; Factor VII; Factor VIII; Factor VIII inhibitor; Factor VIIIc; Factor X; Factor XI; Factor XII; Plasminogen; Protein C and protein S; Thrombin time (TT); Von Willebrand factor (vWF) antigen - Quantitation | ||
| Platelet aggregation | ||
| Factor VIII | ||
| Heparin induced thrombotic thrombocytopenia (HITT) | ||
| Factor XIII deficiency | ||
| Von Willebrand collagen binding assay | ||
| DOAC therapy pre-treated plasma | Lupus anticoagulant | |
| Plasma | Emicizumab levels | |
| Anti-platelet factor 4 (PF4) | ||
| Factor VIII binding assay (vWF Normandy) |
ISO 15189 (2022)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
15 May 2023
| Service | Product | Determinant |
|---|---|---|
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Plasma | Factor VIII inhibitor |
| Factor VIII | ||
| Factor IX | ||
| Emicizumab levels |
Hospital in the Home (Mobile PoCT)
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
15 May 2023
| Service | Product | Determinant |
|---|---|---|
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | International normalised ratio (INR) |
Intensive Care Unit
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
15 May 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Microbiology and Infectious Diseases
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
15 May 2023
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection and identification of crystalline material | Synovial fluid | Crystal detection and identification |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Biopsy specimens; Blood; Cerebrospinal fluid (CSF); Faeces; Fluids; General swabs; Genital specimens; Isolates; Nasal swabs; Pus; Rectal swabs; Respiratory specimens; Sputum; Synovial fluid; Tissues; Urine | Antibiotic susceptibility |
| Bacteria; Pathogenic identification; Pathogenic microorganisms | ||
| Aspirates; Biopsy specimens; Blood; Cerebrospinal fluid (CSF); Faeces; Fluids; General swabs; Genital specimens; Nasal swabs; Pus; Rectal swabs; Respiratory specimens; Sputum; Synovial fluid; Tissues; Urine | Bacteria; Pathogenic microorganisms | |
| Aspirates; Biopsy specimens; Blood; Cerebrospinal fluid (CSF); Faeces; Fluids; General swabs; Genital swabs; Isolates; Nasal swabs; Pus; Rectal swabs; Respiratory specimens; Sputum; Synovial fluid; Tissues; Urine | Bacteria; Pathogenic identification; Pathogenic microorganisms | |
| Antibiotic susceptibility | ||
| Aspirates; Biopsy specimens; Blood; Cerebrospinal fluid (CSF); Faeces; Fluids; General swabs; Genital swabs; Nasal swabs; Pus; Rectal swabs; Respiratory specimens; Sputum; Synovial fluid; Tissues; Urine | Bacteria; Pathogenic microorganisms | |
| Aspirates; Biopsy specimens; Blood; Cerebrospinal fluid (CSF); Fluids; General swabs; Genital swabs; Pus; Respiratory specimens; Sputum; Synovial fluid; Tissues | Bacteria; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Biopsy specimens | Helicobacter pylori | |
| Blood | Staphylococcus aureus; Methicillin resistant Staphylococcus aureus (MRSA) | |
| Blood; Fluids | Bacteria; Pathogenic microorganisms | |
| Faeces | Helicobacter pylori antigen | |
| Gastric biopsy | Urease | |
| Urine | Bacteria; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Blood; Glucose; Ketones; Leucocyte esterase; Nitrite; Proteins; Specific gravity; Urobilinogen; pH | ||
| Bacteria; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | ||
| Legionella antigen | ||
| Microbiology - Bacteriology - Detection of pathogenic bacteria for epidemiological infection control surveillance | Axilla swabs; Faeces; Nasal swabs; Rectal swabs | Carbapenem resistant Enterobacteriaceae (CRE); Methicillin resistant Staphylococcus aureus (MRSA); Vancomycin resistant Enterococci (VRE) |
| Axilla swabs; Nasal swabs | Methicillin resistant Staphylococcus aureus (MRSA) | |
| Bacterial isolates | Carbapenem-resistant organisms (CRO) | |
| Carbapenemase-producing Enterobacterales (CPE) | ||
| Faeces; Rectal swabs | Vancomycin resistant Enterococci (VRE) | |
| Microbiology - Environmental investigations and/or infection control (Clinical non-human testing) | Blood transfusion bags | Bacterial growth - Sterility |
| Blood transfusion bags; Endoscopes; Environmental swabs | Bacterial organism identification | |
| Blood transfusion bags; Endoscopes; Environmental swabs; Tips | Bacterial growth - Sterility; Organism characterisation for patient management | |
| Blood transfusion bags; Environmental swabs; Gastrointestinal endoscopes | Bacterial growth - Sterility | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Isolates | Van A/B |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Nasal swabs; Nasopharyngeal swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) - PCR, RT-PCR |
| Nasal swabs; Nasopharyngeal swabs; Throat swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) - PCR, RT-PCR | |
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Cerebrospinal fluid (CSF); Ear swabs; Fluids; General swabs; Genital swabs; Isolates; Respiratory specimens; Respiratory swabs; Sputum; Tissues; Urine; Wound swabs | Fungi identification; Yeasts identification |
| Cerebrospinal fluid (CSF); Ear swabs; Fluids; General swabs; Genital swabs; Isolates; Respiratory specimens; Tissues; Urine; Wound swabs | Fungi identification; Yeasts identification | |
| Cerebrospinal fluid (CSF); Fluids; General swabs; Isolates; Respiratory specimens; Tissues | Fungi identification; Yeasts identification | |
| Cerebrospinal fluid (CSF); Plasma; Serum | Cryptococcus antigen | |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Faeces | Cysts; Ova; Parasites |
| Worms | ||
| Skin scrapings | Arthropods | |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Bronchial washings; Bronchoalveolar lavage; Serum | Aspergillus galactomannan antigen |
| Cadaveric blood | Hepatitis B virus surface antigen (HBs Ag) - Quantitative; Hepatitis C virus antibody (anti-HCV); Human T-lymphotropic virus type I/II (HTLV-I/II) antibody; Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Human immunodeficiency virus type 1/2 (HIV-1/2) antigen; Syphilis Treponema pallidum total antibody | |
| Cerebrospinal fluid (CSF); Plasma; Serum | Syphilis Treponema pallidum antibody | |
| Cerebrospinal fluid (CSF); Serum | Syphilis Treponema pallidum IgM antibody | |
| Plasma; Serum | Bordetella pertussis IgG; Epstein-Barr virus IgG antibody; Epstein-Barr virus IgM antibody; Helicobacter pylori IgG antibody; Herpes simplex virus type 1 antibody (anti-HSV1) - IgM; Herpes simplex virus type 2 antibody (anti-HSV2) - IgM; Measles IgG antibody; Measles IgM antibody; Mumps virus IgG antibody; Mumps virus IgM antibody; Mycoplasma pneumoniae IgG antibody; Mycoplasma pneumoniae IgM antibody; Parvovirus IgG antibody; Parvovirus IgM antibody; Varicella zoster virus (VZV) IgG antibody; Varicella zoster virus IgM antibody | |
| Coxiella burnetii (Q-fever) IgG phase 1 antibody; Coxiella burnetii (Q-fever) IgG phase 2 antibody; Coxiella burnetii (Q-fever) IgM phase 1 antibody; Coxiella burnetii (Q-fever) IgM phase 2 antibody | ||
| Hepatitis C virus (HCV); Human T-lymphotropic virus type I/II (HTLV-I/II); Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Human immunodeficiency virus type 1/2 (HIV-1/2) antigen | ||
| Dengue virus IgG antibody; Dengue virus IgM antibody; Dengue virus NS1 antigen | ||
| Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies | ||
| Human T-lymphotropic virus type I/II (HTLV-I/II) antibody | ||
| Legionella longbeachae antibody; Legionella pneumophila serogroup 1 antibody; Legionella pneumophila serogroup 2 antibody | ||
| Cytomegalovirus antibody (anti-CMV) IgG; Cytomegalovirus antibody (anti-CMV) IgM; Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis A virus antibody (anti-HAV) - Total; Hepatitis B virus core antibody (anti-HBc) - IgM; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis B virus surface antigen (HBs Ag) neutralisation; Hepatitis C virus antibody (anti-HCV) - IgG; Herpes simplex virus type 2 antibody (anti-HSV2) - IgG; Herpes simplex type 1 antibody (anti-HSV1) - IgG; Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Human immunodeficiency virus type 1/2 (HIV-1/2) antigen; Rubella IgG antibody; Rubella IgM antibody; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) antibody; Syphilis Treponema pallidum antibody; Toxoplasma gondii IgG antibody; Toxoplasma gondii IgM antibody | ||
| Japanese encephalitis virus (JEV) IgG antibody; Japanese encephalitis virus (JEV) IgM antibody | ||
| Human T-lymphotropic virus type I/II (HTLV-I/II) | ||
| Coxiella burnetii (Q-fever) IgG phase 2 antibody; Coxiella burnetii (Q-fever) IgM phase 2 antibody | ||
| Syphilis Treponema pallidum antibody | ||
| Serum | Fluorescent Treponemal antibody | |
| Hepatitis D virus antibody (anti-HDV) | ||
| Rickettsia rickettsii; Rickettsia typhi antibody | ||
| Brucella IgG antibody; Brucella IgM antibody | ||
| Schistosoma mansoni IgG antibody | ||
| Anti-streptolysin O (ASOT) | ||
| Leptospira IgM antibody | ||
| Barmah forest virus IgG antibody; Barmah forest virus IgM antibody; Ross River virus IgG antibody; Ross River virus IgM antibody | ||
| Strongyloides spp. antibody |
Theatre Suites
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
15 May 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Transfusion Medicine
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jan 2027
Last Activity Date
15 May 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Blood; Snake bite site; Swabs; Urine | Snake venom detection |
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | Platelet aggregation |
| Viscoelastic haemostatic testing (VHT) | ||
| Haematology - Investigation of haemolysis | Blood; Plasma | Cold agglutinins |
| Immunohaematology - Blood group antibody detection | Blood; Plasma | Other blood group systems; Rh phenotypes |
| Immunohaematology - Blood grouping | Blood; Plasma | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood | Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Direct antiglobulin test (DAT, direct Coombs test) | ||
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood; Plasma | Antibody absorption |
| Other blood group antibodies; Red blood cell phenotyping; Rh | ||
| Antibody elution | ||
| Plasma | Antibody titration | |
| Immunohaematology - Investigation of blood transfusion reactions | Blood products | Antibodies |
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunohaematology - Storage and distribution of blood and blood components | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2348
Site No.
24039
Print date
22 Nov 2024
END OF SCOPE